Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Immune recall improves antibody durability and breadth to SARS-CoV-2 variants
Yuezhou Chen, Pei Tong, Noah B. Whiteman, et al.
Science Immunology (2022) Vol. 7, Iss. 78
Open Access | Times Cited: 63

Showing 26-50 of 63 citing articles:

Single-shot dendritic cell targeting SARS-CoV-2 vaccine candidate induces broad, durable and protective systemic and mucosal immunity in mice
Nicholas You Zhi Cheang, Kai Sen Tan, Peck Szee Tan, et al.
Molecular Therapy (2024) Vol. 32, Iss. 7, pp. 2299-2315
Closed Access | Times Cited: 2
Humoral and cellular immune responses in persons with rheumatoid arthritis after a third dose of mRNA COVID-19 vaccine
Sara K. Tedeschi, Daniel H. Solomon, Yuezhou Chen, et al.
Seminars in Arthritis and Rheumatism (2023) Vol. 59, pp. 152177-152177
Open Access | Times Cited: 5
Changes in serum-neutralizing antibody potency and breadth post-SARS-CoV-2 mRNA vaccine boost
Manoj S. Nair, Ruy M. Ribeiro, Maple Wang, et al.
iScience (2023) Vol. 26, Iss. 4, pp. 106345-106345
Open Access | Times Cited: 5
Genotype–phenotype landscapes for immune–pathogen coevolution
Alief Moulana, Thomas Dupic, Angela M. Phillips, et al.
Trends in Immunology (2023) Vol. 44, Iss. 5, pp. 384-396
Open Access | Times Cited: 5
Boosting with an aerosolized Ad5-nCoV elicited robust immune responses in inactivated COVID-19 vaccines recipients
Zhe Zhang, Shipo Wu, Yawei Liu, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 5
Deep learning-guided selection of antibody therapies with enhanced resistance to current and prospective SARS-CoV-2 Omicron variants
Lester Frei, Beichen Gao, Jiami Han, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access | Times Cited: 5
Antibody‐mediated SARS‐CoV‐2 entry in cultured cells
Md. Golam Kibria, Christy L. Lavine, Weichun Tang, et al.
EMBO Reports (2023) Vol. 24, Iss. 12
Open Access | Times Cited: 5
Effectiveness of BNT162b2 mRNA vaccine third doses and previous infection in protecting against SARS-CoV-2 infections during the Delta and Omicron variant waves; the UK SIREN cohort study September 2021 to February 2022
Victoria Hall, Ferdinando Insalata, Sarah Foulkes, et al.
Journal of Infection (2023) Vol. 88, Iss. 1, pp. 30-40
Open Access | Times Cited: 5
Mechanistic models of humoral kinetics following COVID-19 vaccination
Daniel Stocks, Amy Thomas, Adam Finn, et al.
medRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access | Times Cited: 1
Diminished neutralizing activity against the XBB1.5 strain in 55.9% of individuals post 6 months COVID-19 mRNA booster vaccination: insights from a pseudovirus assay on 1,353 participants in the Fukushima vaccination community survey, Japan
Tianchen Zhao, Yuta Tani, Chieko Makino‐Okamura, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 1
Modelling the impact of hybrid immunity on future COVID-19 epidemic waves
Thao P. Le, Isobel Abell, Eamon Conway, et al.
BMC Infectious Diseases (2024) Vol. 24, Iss. 1
Open Access | Times Cited: 1
COVID-19 point-of-care tests can identify low-antibody individuals: In-depth immunoanalysis of boosting benefits in a healthy cohort
Michael L. Mallory, Jennifer E. Munt, Tara M. Narowski, et al.
Science Advances (2024) Vol. 10, Iss. 24
Open Access | Times Cited: 1
Omicron SARS-CoV-2 infection management and outcomes in patients with hematologic disease and recipients of cell therapy
José Luís Piñana, Lourdes Vázquez, Inmaculada Heras, et al.
Frontiers in Oncology (2024) Vol. 14
Open Access | Times Cited: 1
Hybrid Immunity against SARS-CoV-2 Variants: A Narrative Review of the Literature
Panagiota Tsagkli, Maria Geropeppa, Ioanna Papadatou, et al.
Vaccines (2024) Vol. 12, Iss. 9, pp. 1051-1051
Open Access | Times Cited: 1
Serial infection with SARS-CoV-2 Omicron BA.1 and BA.2 following three-dose COVID-19 vaccination
Hope R. Lapointe, Francis Mwimanzi, Peter K. Cheung, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 8
Impact of Age and Severe Acute Respiratory Syndrome Coronavirus 2 Breakthrough Infection on Humoral Immune Responses After Three Doses of Coronavirus Disease 2019 mRNA Vaccine
Francis Mwimanzi, Hope R. Lapointe, Peter K. Cheung, et al.
Open Forum Infectious Diseases (2023) Vol. 10, Iss. 3
Open Access | Times Cited: 4
Live‐virus neutralization of the omicron variant in children and adults 14 months after SARS‐CoV‐2 wild‐type infection
Maximilian Stich, Louise Benning, Claudius Speer, et al.
Journal of Medical Virology (2023) Vol. 95, Iss. 3
Open Access | Times Cited: 4
Effectiveness of BNT162b2 mRNA vaccine third doses and previous infection in protecting against SARS-CoV-2 infections during the Delta and Omicron variant waves; the UK SIREN cohort study September 2021 to February 2022
Victoria Hall, Ferdinando Insalata, Sarah Foulkes, et al.
medRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access | Times Cited: 4
Distinct immune responses in the early phase to natural SARS‐CoV‐2 infection or vaccination
Pai Peng, Haijun Deng, Zhihong Li, et al.
Journal of Medical Virology (2022) Vol. 94, Iss. 12, pp. 5691-5701
Open Access | Times Cited: 7
Wastewater as a back door to serology?
Marie LittleFawn Agan, William R. Taylor, Isaiah Young, et al.
medRxiv (Cold Spring Harbor Laboratory) (2022)
Open Access | Times Cited: 6
Longer intervals between SARS‐CoV‐2 infection and mRNA‐1273 doses improve the neutralization of different variants of concern
Javier García‐Pérez, Mercedes Bermejo, Almudena Ramírez‐García, et al.
Journal of Medical Virology (2023) Vol. 95, Iss. 3
Open Access | Times Cited: 3
mRNA Vaccine-Induced SARS-CoV-2 Spike-Specific IFN-γ and IL-2 T-cell Responses are Predictive of Serological Neutralization and are Transiently Enhanced by Pre-Existing Cross-Reactive Immunity
Philip Samaan, Chapin S. Korosec, Patrick Budylowski, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access
Pediatric antibody responses to SARS-CoV-2 after infection and vaccination in Calgary, Canada
Leah J. Ricketson, Emily J. Doucette, Isabella Alatorre, et al.
BMC Infectious Diseases (2024) Vol. 24, Iss. 1
Open Access
Rewired type I IFN signaling is linked to age-dependent differences in COVID-19
L. A. Petrov, Sophia Brumhard, Sebastian Wisniewski, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access
Longevity of antibody responses is associated with distinct antigen-specific B cell subsets early after infection
Lisan H. Kuijper, Christine Kreher, George Elias, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access

Scroll to top